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Abstract
Background: The epidemiology of acute pancreatitis in the United States is largely unknown,
particularly episodes that lead to an emergency department (ED) visit. We sought to address this
gap and describe ED practice patterns.
Methods: Data were collected from the National Hospital Ambulatory Medical Care Survey
between 1993 and 2003. We examined demographic factors and ED management including
medication administration, diagnostic imaging, and disposition.
Results: ED visits for acute pancreatitis increased over the study period from the 1994 low of
128,000 visits to a 2003 peak of 318,000 visits (p = 0.01). The corresponding ED visit rate per
10,000 U.S. population also increased from 4.9 visits (95%CI, 3.1–6.7) to 10.9 (95%CI, 7.6–14.3) (p
= 0.01). The average age for patients making ED visits for acute pancreatitis during the study period
was 49.7 years, 54% were male, and 27% were black. The ED visit rate was higher among blacks
(14.7; 95%CI, 11.9–17.5) than whites (5.8; 95%CI, 5.0–6.6). At 42% of ED visits, patients did not
receive analgesics. At 10% of ED visits patients underwent CT or MRI imaging, and at 13% of visits
they underwent ultrasound testing. Two-thirds of ED visits resulted in hospitalization. Risk factors
for hospitalization were older age (multivariate odds ratio for each increasing decade 1.5; 95%CI,
1.3–1.8) and white race (multivariate odds ratio 2.3; 95%CI, 1.2–4.6).
Conclusion: ED visits for acute pancreatitis are rising in the U.S., and ED visit rates are higher
among blacks than whites. At many visits analgesics are not administered, and diagnostic imaging is
rare. There was greater likelihood of admission among whites than blacks. The observed race
disparities in ED visit and admission rates merit further study.
Background
Acute pancreatitis is a relatively common condition, but
the incidence throughout the Western world varies
widely. For example, hospital admission rates of 1.5 cases
per 10,000 in Southern England and 7.3 per 10,000 in
Finland have been reported in various European studies.
In addition, investigators have described varied demo-
graphic characteristics and treatment patterns for different
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European populations [1-4]. No European studies have
specifically examined emergency department (ED) visit
rates for acute pancreatitis. In the U.S., no national studies
have described the epidemiology of acute pancreatitis
from any perspective (i.e. hospital admission rates, ED
visit rates, or visits to all healthcare facilities), or the initial
evaluation and treatment of pancreatitis patients in U.S.
EDs. This national study of U.S. ED visits over an 11-year
period thus stands to provide the most complete epidemi-
ologic picture to date of pancreatitis in the U.S., offering
insight into recent trends in ED visits, the overall burden
of the disease in the U.S., and the demographic character-
istics of patients.
Methods
Data from the ED component of the National Hospital
Ambulatory Medical Care Survey (NHAMCS) from 1993–
2003 were combined for analysis [5-15]. The NHAMCS is
a 4-stage probability sample of visits to non-institutional
general and short stay hospitals, excluding Federal, mili-
tary, and Veterans Administration hospitals, located in the
50 States and the District of Columbia [16,17]. The
NHAMCS is conducted annually and covers geographic
primary sampling units, hospitals within primary sam-
pling units, EDs within hospitals, and patients within
EDs. Trained hospital staff collect data during a randomly
assigned 4-week data period for each sampled hospital,
approximately once every 15 months [18]. Review of data
collection is performed by a U.S. Bureau of Census field
supervisor. Quality control includes computer checks to
assess inconsistencies with value ranges, a two-way 10-
percent independent procedure for medical and drug cod-
ing, and adjudication by the National Center for Health
Statistics (NCHS) for ambiguous or illegible responses for
fields including reasons for visit and diagnosis. The non-
response rate for most items is less than 5%, and error
rates are less than 2% for items that require medical cod-
ing [17]. When the data collection forms are completed,
they are sent to Constella Group Inc., Durham, North
Carolina where they are coded by experienced personnel
using the International Classification of Disease, Ninth Revi-
sion, Clinical Modification (ICD-9-CM). National estimates
are obtained through use of assigned patient visit weights
and are rounded to the nearest thousand. A multistage
estimation procedure consists of inflation by reciprocals
of the sampling selection probabilities, adjustment for
non-response, and a population weighting ratio adjust-
ment. The NHAMCS data form is devoid of patient iden-
tifying characteristics. A more detailed description of the
NHAMCS data collection and estimation procedures is
available for review at the National Hospital Ambulatory
Medical Care Survey (NHAMCS) Public-use Data Files
web page and in the technical notes section of each year's
NHAMCS Emergency Department Summary [19,20].
The NHAMCS allows for specification of up to three phy-
sician diagnoses. In this study, we first identified all visit
records with the physician diagnosis ICD-9-CM 577.0
(acute pancreatitis) in any position and determined esti-
mated ED visits and visit rates. For all subsequent analysis
we then excluded visit records if ICD-9-CM 577.0
appeared only as the third-listed diagnosis or if ICD-9-CM
577.1 (chronic pancreatitis) appeared as a physician diag-
nosis in any diagnostic position. This was done to mini-
mize possible problems from miscoding of chronic
pancreatitis exacerbations as episodes of acute pancreati-
tis, and to eliminate equivocal diagnoses of acute pancre-
atitis.
We examined ED visits by patient age, sex, race, Hispanic
ethnicity, and insurance status and by hospital metropol-
itan statistical area (MSA) status and region (Northeast,
Midwest, South and West). MSA and U.S. region catego-
ries represent standardized geographical divisions defined
by the U.S. Bureau of the Census; essentially, a hospital in
a MSA is urban [21,22]. Hispanic ethnicity was not
imputed by the NHAMCS from 1997–2002, and thus data
on Hispanic ethnicity are not available for those years.
U.S. visit rates were computed using mid-year age, sex,
race, ethnicity, and metropolitan status specific popula-
tion estimates from the U.S. Census Bureau; all rates were
reported per 10,000 individuals per year for the U.S. resi-
dent population. Investigators also re-examined primary
results for visit rates using the civilian population, as rec-
ommended by NCHS, and results were similar (data not
shown). Overall average annual rates for the entire study
period, where reported (such as in Table 1), were calcu-
lated by dividing the total number of estimated ED visits
by the sum of the midyear estimates for each of the eleven
years of the study. ED management focused on medica-
tions, diagnostic imaging, and ED disposition (e.g., hospi-
tal admission). Disease severity data are limited but
include urgency at triage. To keep analyses between earlier
and later years consistent, we coded visits that occurred
after a change in coding in 1997 (1997–2003), as "urgent/
emergent" if immediacy to be seen was recorded as "less
than 15 minutes" or "15–60 minutes," and as "non-
urgent" if recorded as ">1–2 hours" or longer. From
1993–94 up to five medications were recorded per visit,
from 1995–2002 up to six medications were recorded per
encounter, and in 2003 up to eight medications were
recorded per encounter, with medications coded as per
published NCHS definitions [23-25]. All recorded medi-
cations were considered for analysis. Therapeutic class of
medication (eg. "antibiotic" or "analgesic") was based on
the National Drug Code Directory.
We performed data management and analysis using
STATA 9.0 (StataCorp, College Station, TX). A masked
ultimate cluster sample design was used to estimate vari-BMC Emergency Medicine 2007, 7:1 http://www.biomedcentral.com/1471-227X/7/1
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ance. NCHS considers an estimate to be unreliable if it has
a relative standard error (SE) of more than 30%. In addi-
tion, estimates based on fewer than 30 records are consid-
ered inherently unreliable, regardless of their SE. For the
current analysis, we determined point estimates and 95%
confidence intervals (CIs) for ED visits – both absolute
numbers and population rates – as well as for visits by
patient, age, sex, race, ethnicity, geographic region, and
MSA status. Visits also were analyzed for frequency of hos-
pital admission, analgesic administration (including nar-
cotics), computed tomography (CT) or magnetic
resonance imaging (MRI) use, and ultrasound use. CT,
MRI, and ultrasound use were not recorded in 1993–94,
so these results describe practice patterns from 1995–
2003. Pearson's chi-square was used to assess differences
between groups. Chi-square for trend was used to evaluate
trends over the 11-year period. Visits were combined into
2-year groups (with the exception of 2003) to determine
whether trends existed for total visits, or by sex or race.
Multivariate logistic regression was used to evaluate inde-
pendent predictors of hospital admission. Two-sided p-
values of less than 0.05 were considered statistically sig-
nificant. Our study was conducted with the approval of
the Massachusetts General Hospital Institutional Review
Board.
Results
The 1993–2003 NHAMCS ED dataset included 304,697
ED visits, of which 649 were coded as acute pancreatitis.
These visits represent an estimated 2,235,000 (95%CI,
1,983,000 – 2,487,000) ED visits for "acute pancreatitis"
and an overall average annual ED visit rate of 7.4 (95%CI,
6.6–8.3) per 10,000 U.S. population for the entire 11-year
study period. Exclusion of sample records that were also
Table 1: Emergency Department Visits for Acute Pancreatitis in the U.S. by Patient and Hospital Characteristics; 1993–2003.
n Cumulative 
Number of 
Visits
95% Confidence 
Interval
Average Annual Visit Rate 
per 10,000 US Population
95% 
Confidence 
Interval
Average Annual Visit 
Rate per 10,000 ED 
Visits
95% 
Confidence 
Interval
Overall (acute pancreatitis 
in any diagnostic position, 
without exclusions)
649 2,235,000 1,983,000 2,487,000 7.4 7.0 7.6 20.2 18.0 22.0
Overall (after imposing 
exclusion criteria)
595 2,052,000 1,821,000 2,282,000 6.8 6.1 7.6 18.5 16.4 20.6
Age Group (years)
<10 8 nc* nc nc nc nc nc nc nc nc
10–19 10 nc nc nc nc nc nc nc nc nc
20–29 69 234,000 167,000 300,000 5.2 3.7 6.6 12.6 9.0 16.2
30–39 104 288,000 220,000 355,000 5.5 4.2 6.9 16.7 12.8 10.7
40–49 153 508,000 402,000 615,000 10.6 8.4 12.8 37.4 29.5 45.2
50–59 92 346,000 251,000 441,000 10.3 7.5 13.1 39.4 28.6 50.2
60–69 76 269,000 189,000 349,000 11.0 7.7 14.3 40.1 28.2 52.1
70–79 48 212,000 135,000 289,000 11.2 7.1 15.3 30.7 19.5 41.8
80+ 35 136,000 80,000 192,000 13.0 7.7 18.4 22.0 12.9 31.1
Sex
Female 265 954,000 797,000 1,110,000 6.2 5.2 7.2 16.3 13.6 18.9
Male 330 1,098,000 945,000 1,251,000 7.5 5.4 7.6 21.0 15.3 21.3
Race
White 407 1,424,000 1,225,000 1,624,000 5.8 5.0 6.6 16.8 14.5 19.2
Black 164 559,000 453,000 666,000 14.7 11.9 17.5 24.0 19.4 28.6
Other 24 nc nc nc nc nc nc nc nc nc
Ethnicity†
Hispanic 64 198,000 130,000 266,000 5.7 3.7 7.6 20.8 13.7 28.0
Non-Hispanic 419 1,484,000 1,286,000 1,683,000 5.6 4.8 6.3 21.2 18.4 24.0
U.S. Region
Northeast 145 414,000 306,000 521,000 7.2 5.3 9.0 19.0 14.1 23.9
Midwest 122 441,000 343,000 539,000 6.3 4.9 7.8 15.6 12.2 19.1
South 187 740,000 613,000 866,000 7.0 5.8 8.2 18.1 15.0 21.2
West 141 458,000 331,000 584,000 6.8 5.0 8.7 23.0 16.6 29.3
Metropolitan Status
Metropolitan 526 1,692,000 1,466,000 1,917,000 7.0 6.1 8.0 19.5 16.9 22.1
Non-metropolitan 69 360,000 228,000 492,000 5.8 3.7 8.0 15.0 9.5 20.5
*Not calculable because sample <30 or relative standard error >30%
†21% sample missingBMC Emergency Medicine 2007, 7:1 http://www.biomedcentral.com/1471-227X/7/1
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coded as "chronic pancreatitis" and sample records with
acute pancreatitis as the third-listed diagnosis left 595 vis-
its, which are the focus of all subsequent analyses. These
visits represent an estimated 2,052,000 (95%CI,
1,822,000 – 2,282,000) ED visits for acute pancreatitis
and an overall rate of 6.8 (95%CI, 6.1–7.6) ED visits per
10,000 U.S. population for the entire 11-year study
period. At triage, 76% (95%CI, 71–81%) were considered
urgent/emergent.
Demographic characteristics of ED visits for acute pancre-
atitis are shown in Table 1. In brief, population rates were
positively associated with age, with a significant increase
at the fifth decade (age 40–49) that was relatively stable
thereafter. The ED visit rate per 10,000 U.S. population
among blacks (14.7; 95%CI, 11.9–17.5) was more than
double that among whites (5.8; 95%CI, 5.0–6.6). Com-
pared to all other ED visits acute pancreatitis visits were
more likely to be made by males (p = 0.01). Rates did not
differ by gender, urban setting, or U.S. region. Insurance
status for ED visits with acute pancreatitis was similar to
that of all other ED visits.
Looking at time trends over the 11-year study period,
there was a significant upward trend in both the absolute
numbers and the population rates for ED visits for acute
pancreatitis (Figure 1; both p for trend < 0.05). The nadir
year for total visits was 1994 with 128,000 visits (95%CI,
81,000 – 175,000) and the peak was 2003 with 318,000
visits (95%CI, 221,000 – 415,000). The population rate
was also lowest in 1994 at 4.9 visits per 10,000 individu-
als (95%CI, 3.1–6.7) and peaked in 2003 at 10.9 (95%CI,
7.6–14.3). The observed increases were fairly uniform
across various basic demographic groups, including
adults age 18 and older (p = 0.04), males (p = 0.09),
females (p = 0.09), and whites (p = 0.03). Although rates
for blacks were consistently higher than those for whites
across all years (Figure 2), we did not observe a statisti-
cally significant increase for blacks over the 11-year time
period (p = 0.24).
Analgesics were administered during 58% (95%CI, 53–
63%) of ED visits for acute pancreatitis. Overall, narcotic
analgesics were administered during 40% (95%CI, 35–
46%) of all ED visits, so when analgesics were given they
were most often narcotics. Blacks and whites were equally
likely to receive analgesics (51.1% vs. 60.6%; p = 0.10).
Antibiotics were administered during 9% (95%CI, 6–
11%) of all visits. In terms of imaging, CT scanning or
MRI were performed during 10% (95%CI, 7–13%) of vis-
its, while ultrasound was performed 13% (95%CI, 9–
17%) of the time. These numbers were too small to allow
analysis of trends in imaging. Overall, 65% (95%CI, 60–
69%) of ED visits for acute pancreatitis resulted in admis-
sion to the hospital.
Table 2 provides results of the multivariate logistic regres-
sion model of hospital admission. The only independent
predictors of admission were older age (multivariate odds
ratio of 1.5 for each increasing decade) and white race
(multivariate odds ratio of 2.3). The immediacy with
which the patient should be seen, as perceived at triage,
had a non-significant positive association with admission.
By contrast, gender, ethnicity, insurance type, urban loca-
tion, and U.S. region were not associated with hospital
admission.
Discussion
This study provides the first U.S. estimates of ED visits for
acute pancreatitis. From 1993 through 2003, there has
been a steady increase in the absolute number and popu-
lation rates of ED visits for acute pancreatitis. The number
of estimated ED visits in 2003 (318,000) is approximately
four times a recent U.S. government estimate of 80,000
annual cases [26]. Several European studies have
described an increase in the incidence of acute pancreatitis
in a variety of locations throughout Western Europe [1-
3,27-30]. While these studies purport to describe inci-
dence rates rather than ED visits – some use hospital
admission data only, some include outpatient visits, and
others include autopsy data – due to the lack of data from
the United States and from EDs in general, they provide
the most relevant context for interpreting our data. The
overall rate of ED visits of 6.8/10,000/year that we
describe here is higher than the incidence rates identified
in most European studies, which report incidence rates
from 1.5/10,000/year to 7.3/10,000/year in recent dec-
ades [1-3,27-34]. The 2003 peak of 10.9 ED visits per
10,000 U.S. population was higher than the peak annual
rates in all the studies cited above.
There are several potential methodological explanations
for these results. Our study is ED-based while some of the
European studies cited above were based only on hospital
admissions [2,3,27-30,32,34]. Extrapolating from our
data, in which only 65% of ED visits ended in hospital
admission, our calculated hospital admission rate would
be significantly lower. Nevertheless, other European stud-
ies were prospective and included all healthcare facilities
in the study area including outpatient clinics and the inci-
dence rates reported by these investigators were notably
lower than ours [33,35].
Our study did not impose strict criteria for the diagnosis
of acute pancreatitis. The possibility that some of our sam-
pled and selected ED visits did not have pancreatitis at all,
or suffered exacerbations of chronic pancreatitis rather
than episodes of acute pancreatitis is real. As noted above,
though the NHAMCS reports a less than 2% error for
items involving medical coding generally, the exact accu-
racy of pancreatitis diagnoses in the database is unknown.BMC Emergency Medicine 2007, 7:1 http://www.biomedcentral.com/1471-227X/7/1
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This problem of assuring accurate diagnosis was encoun-
tered in three large registry-based European studies with
the capacity for chart review and validation (which our
study lacks due to the anonymous nature of the
NHAMCS). These showed from 82% to 90% rates of accu-
rate diagnosis and coding for cases entered as acute pan-
creatitis [2,3,28]. All of these registries contained
inpatient admissions, and so benefited from a sometimes
lengthy hospital stay to clarify diagnosis – a luxury not
afforded by the ED. In this respect, it is reassuring for our
data that the National Hospital Discharge Summary, the
largest national database for inpatient admissions in the
U.S. has similarly documented a rise in hospital admis-
sions for acute pancreatitis from 108,000 in 1987 to
224,000 in 2003 and that the 2003 figure for hospital
admissions correlates closely with the number which
would be computed from our ED visit and hospital
admission rates [36,37]. Because of its anonymous nature,
the NHAMCS database does not allow identification of
repeat ED visits by the same patient for the same episode
of acute pancreatitis. This may be mitigated somewhat by
the inclusion of each hospital in the sampling frame for
only one month out of approximately every 15, and is
likely to have a small impact at most. While the inclusion
of sample records without true acute pancreatitis or the
capture of multiple visits for the same episode of acute
pancreatitis would artificially elevate the observed
caseload, one of the European studies cited documented
capture of only 76% of a cohort of known pancreatitis
patients by the national database, a source of error that
would offset the over counting in terms of total numbers
of cases [3]. Another study has shown that acute pancrea-
titis case selection based on reliance on diagnostic lists as
in our study misses a large quantity of cases [38]. Despite
these known limitations of registry-based studies and the
difficulty of precisely validating NHAMCS for this partic-
ular cohort of cases, our selection criteria fell well within
the standard methodology used to establish the literature
in this field, and indeed were quite conservative.
Thus, we believe that methodologic reasons alone are
unlikely to explain the high ED visit rates we describe,
which are significantly higher than most of the incidence
rates reported by European investigators. While NHAMCS
itself does not allow calculation of incidence rates, we
consider a higher incidence rate of acute pancreatitis in
the U.S. to be the simplest explanation for the relatively
high ED visit rate in this country. Methodological differ-
ences between our study and the numerous European
studies cited cannot explain the observed upward trend in
the overall number and rate of ED visits for acute pancre-
atitis in the U.S., nor can they explain differences in visit
rates between subgroups within our study. Our selection
criteria did not change for the different years of the study
period, were applied uniformly, and no significant
changes occurred in diagnostic modalities used in acute
pancreatitis during the study period.
The rate of ED visits for acute pancreatitis among U.S.
blacks was significantly higher than that among whites
throughout the study period. To our knowledge, this is the
first time that this racial disparity has been described in a
large-scale nationwide study. This study is unable to fur-
ther investigate the cause of this race disparity since the
etiology of each case and whether or not it was a recurrent
episode is not known. Because we cannot track the etiol-
ogy of acute pancreatitis in any of our study subjects and
do not know how many of the cases were recurrent, nei-
ther an explanation nor a means of rectifying this impor-
tant racial disparity is possible. However, we believe that
these results provide a compelling argument for future
research on this topic.
Blacks were significantly less likely to be admitted than
whites when controlling for age, insurance type, hospital
location, and urgency at triage. This finding deserves par-
ticular attention given the high population rate of ED vis-
its for acute pancreatitis for blacks, and has several
possible explanations. Blacks in our study may have pre-
sented with milder pancreatitis than whites. Some studies
have suggested that minority patients are more likely to
Total Emergency Department Visits and Visit Rates for Acute  Pancreatitis in the U.S. 1993–2003 Figure 1
Total Emergency Department Visits and Visit Rates 
for Acute Pancreatitis in the U.S. 1993–2003. Annual 
ED Visits and Visit Rates for acute pancreatitis in the U.S. 
1993–2003. Data are grouped in two-year blocks with the 
exception of 2003.
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use the ED as a source of primary care and more likely to
present with non-urgent conditions [39]. While the
NHAMCS does not provide many objective measures of
disease severity, our observed disparity in admission like-
lihood persisted when we controlled for urgency at triage.
Hospital differences may account for the disparity – hos-
pitals treating blacks may be overcrowded, understaffed,
or poorly funded. These hospitals may not discriminate
between the black and white patients they treat, but
because their patient population is disproportionately
black, this phenomenon may produce the kinds of dispar-
ity we observed [40,41]. Patient decisions cannot be
assessed with our data, and blacks in our study population
may have declined admission in equivocal circumstances,
while whites were more prone to accept. Finally, racial dis-
crimination cannot be excluded and race-based differ-
ences in treatment and disposition of a variety of types of
patients have been reported [42-44]. Variations in ethnic-
ity, insurance type, urban setting, or U.S. region did not
correlate with decision to admit.
The overall admission rate in our study was 65%. We are
not aware of prior studies that have examined acute pan-
creatitis from the perspective of the ED so there are little
(if any) data with which to compare this figure. Some
European investigators have implied that in their study
populations essentially all patients diagnosed with pan-
creatitis, even those diagnosed as outpatients, were
referred for hospital admission [35]. We do not know
how many of the people discharged from the ED in our
study failed outpatient management and returned for
admission. The very fact that the number of cases admit-
ted directly from the ED to intensive care units (ICUs) is
too small for reliable statistical extrapolation, illustrates
the relative infrequency of initial admission to the ICU.
This is in spite of estimates that between 14 and 20% of
acute pancreatitis cases are considered to be "severe"
[26,30,34]. We do not know how many of our admitted
patients went on to be admitted to the ICU during their
hospital stay, and at what point in the stay that might have
happened, nor if initial admission to the ICU would have
had any positive impact on the care of patients with this
type of hospital course. All of these questions merit study
and our data provide a foundation on which to build such
studies. In the meantime, however, our data suggest that
our population suffered from mild pancreatitis at the time
of presentation, that previous estimates of the percentage
of acute pancreatitis cases becoming severe are overstated,
or that patients with severe pancreatitis are frequently
admitted to low acuity inpatient units, as indeed has been
noted by others [27]. In light of this latter possibility, it is
reassuring that the one piece of information that we have
available to us that is associated with both disease severity
and prognosis – age – was independently associated with
an increased likelihood of admission to the hospital (as
noted, ICU admission numbers were too small for this
type of analysis) [45,46].
Overall, diagnostic imaging was rarely used during ED vis-
its for acute pancreatitis. CT scanning can be helpful in
establishing the diagnosis of pancreatitis when it is in
doubt and may be prognostically useful, though it is more
frequently reserved for analyzing complications of severe
acute pancreatitis such as necrosis, abscess, or pseudocyst
[47,48]. Ultrasound is less sensitive for confirming the
diagnosis of acute pancreatitis, but by detecting gallstones
may suggest a biliary etiology, though this distinction is
seldom important to make in the ED [49]. Infrequent use
of these tests in the ED is probably appropriate.
Our data yield a variety of interesting questions that are
beyond the scope of this study. For example, NHAMCS
data do not allow us to evaluate the etiology of each attack
of acute pancreatitis. The development of the International
Classification of Disease, 10th Revision, Clinical Modification,
which features distinct codes for alcoholic and biliary
pancreatitis will likely aid future investigators in this
regard. We could not determine whether a case repre-
sented a first attack or a recurrent episode, a limitation of
the anonymous nature of the NHAMCS and one that
could be addressed by a prospective audit. Likewise, we
could not evaluate mortality or any other outcomes
beyond the ED, nor could we analyze care after admission
to the hospital. Nationwide practice patterns regarding
length and cost of hospital stay, rates of ICU admission,
Emergency Department Visit Rates for Acute Pancreatitis by  Race, 1993–2003 Figure 2
Emergency Department Visit Rates for Acute Pan-
creatitis by Race, 1993–2003. Visit rates for blacks and 
whites with acute pancreatitis in U.S. Emergency Depart-
ments from 1993–2003. Figures are 2-year annual averages, 
with the exception of 2003. P for trend = 0.03 for whites, 
indicating a significant upward trend during the study period. 
P for trend = 0.24 for blacks, indicating that there was no sig-
nificant upward trend.
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the use of antibiotics, the use of invasive therapies such as
endoscopic retrograde cholangiopancreatography, percu-
taneous drainage, or surgery, and the use of enteral versus
parenteral nutrition in inpatients with acute pancreatitis
are essentially unknown. A large-scale study using nation-
wide inpatient data could address these large knowledge
gaps in this important but relatively understudied condi-
tion.
Conclusion
Our study provides the most complete epidemiologic pic-
ture to date of acute pancreatitis in the U.S. ED visits for
acute pancreatitis are rising, and ED visit rates are higher
among blacks than whites. Analgesics are not adminis-
tered during many ED visits. Diagnostic imaging in the ED
is rare. Most patients are admitted to the hospital, with
greater likelihood of admission among whites than
blacks. This study is the first to describe a recent increase
in pancreatitis cases in U.S. EDs, the first to note a marked
racial disparity in the rates of ED visits for acute pancrea-
titis, and the first to note a race-associated disparity in
hospital admission patterns. We hope these data will
stimulate further research into the causes of these impor-
tant findings.
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